TABLE OF CONTENTS

1. INTRODUCTION 24
1.1. OBJECTIVES OF THE STUDY 24
1.2. MARKET DEFINITION 24
1.3. OVERVIEW OF NORTH AMERICA ANTI-SNORING DEVICES AND SNORING MARKET 24
1.4. CURRENCY AND PRICING 25
1.5. LIMITATION 25
1.6. MARKETS COVERED 26
2. MARKET SEGMENTATION 28
2.1. MARKETS COVERED 28
2.2. GEOGRAPHIC SCOPE 29
2.3. YEARS CONSIDERED FOR THE STUDY 30
2.4. CURRENCY AND PRICING 30
2.5. RESEARCH METHODOLOGY 31
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
2.7. SECONDARY SOURCES 35
2.8. ASSUMPTIONS 35
3. MARKET OVERVIEW 36
3.1. DRIVERS 38
3.2. RESTRAINTS 40
3.3. OPPORTUNITIES 41
3.4. CHALLENGES 42
4. EXECUTIVE SUMMARY 43
5. PREMIUM INSIGHTS 46
?
6. NORTH AMERICA ANTI-SNORING DEVICES AND SNORING MARKET,
BY PRODUCT TYPE 49
6.1. OVERVIEW 59
6.2. ORAL APPLIANCES/MOUTHPIECES 61
6.2.1. MANDIBULAR ADVANCEMENT DEVICES (MADS) 63
6.2.1.1. NON-CUSTOM MADS 63
6.2.1.2. CUSTOM-MADE MADS 63
6.2.2. TONGUE-RETAINING DEVICES (TRDS) 63
6.3. NASAL DEVICES 64
6.3.1. EXTERNAL NASAL DILATORS 65
6.3.2. OTHER NASAL DEVICES 65
6.3.2.1. NASAL STENTS 66
6.3.2.2. NASAL CLIPS 66
6.3.2.3. SEPTAL STIMULATORS 67
6.3.2.4. NASAL CONES 67
6.3.2.5. OTHERS 67
6.4. POSITION CONTROL DEVICES 68
6.5. CHIN STRAPS 69
6.6. EPAP THERAPY DEVICES 70
6.7. CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES 71
?
7. NORTH AMERICA ANTI-SNORING DEVICES AND SNORING SURGERY MARKET,
BY END-USER 72
7.1. OVERVIEW 73
7.2. HOSPITALS 75
7.3. COMMUNITY HEALTHCARE 76
7.4. SLEEP CLINICS 77
7.5. HOME HEALTHCARE 78
7.6. OTHERS 79
8. NORTH AMERICA ANTI-SNORING DEVICES AND SNORING SURGERY MARKET,
BY TYPE 80
8.1. OVERVIEW 81
8.2. UVULOPALATOPHARYNGOPLASTY (UPPP) 82
8.3. LASER-ASSISTED UVULOPALATOPLASTY (LAUP) 83
8.4. RADIO FREQUENCY ABLATION (SOMNOPLASTY) 84
8.5. PILLAR PROCEDURE 85
8.6. PALATAL STIFFENING PROCEDURES 86
8.7. INJECTION SNOREPLASTY/SCLEROTHERAPY 87
8.8. OTHER ANTI-SNORING SURGICAL PROCEDURES 88
9. NORTH AMERICA ANTI-SNORING DEVICES AND SNORING SURGERY MARKET, BY DISTRIBUTION CHANNEL 89
9.1. OVERVIEW 90
9.2. RETAIL 92
9.3. DIRECT SALES 93
10. NORTH AMERICA ANTI-SNORING DEVICES AND SNORING MARKET,
BY GEOGRAPHY 101
10.1. OVERVIEW 102
10.2. NORTH AMERICA 109
10.2.1. U.S. 910
10.2.2. CANADA 101
10.2.3. MEXICO 104
11. COMPANY LANDSCAPE 221
11.1. COMPANY SHARE ANALYSIS; NORTH AMERICA 221
12. COMPANY PROFILE. 226
12.1. SLEEPING WELL, LLC 293
12.1.1. COMPANY OVERVIEW 293
12.1.2. COMPANY SNAPSHOT 293
12.1.3. PRODUCT PORTFOLIO 293
12.1.4. RECENT DEVELOPMENTS 294
12.2. APNEA SCIENCES CORPORATION 294
12.2.1. COMPANY OVERVIEW 294
12.2.2. COMPANY SNAPSHOT 294
12.2.3. PRODUCT PORTFOLIO 294
12.2.4. RECENT DEVELOPMENTS 295
12.3. THE PURE SLEEP COMPANY 296
12.3.1. COMPANY OVERVIEW 296
12.3.2. COMPANY SNAPSHOT 296
12.3.3. PRODUCT PORTFOLIO 296
12.3.4. RECENT DEVELOPMENTS 296
12.4. KONINKLIJKE PHILIPS N.V. 297
12.4.1. COMPANY OVERVIEW 297
12.4.2. REVENUE ANALYSIS 297
12.4.3. PRODUCT PORTFOLIO 298
12.4.4. RECENT DEVELOPMENTS 299
12.5. SOMNOMED 300
12.5.1. COMPANY OVERVIEW 300
12.5.2. REVENUE ANALYSIS 300
12.5.3. PRODUCT PORTFOLIO 301
12.5.4. RECENT DEVELOPMENTS 301
12.6. FISHER AND PAYKEL HEALTHCARE LIMITED. 302
12.6.1. COMPANY OVERVIEW 302
12.6.2. REVENUE ANALYSIS 302
12.6.3. PRODUCT PORTFOLIO 303
12.6.4. RECENT DEVELOPMENTS 304
12.7. RESMED 305
12.7.1. COMPANY OVERVIEW 305
12.7.2. REVENUE ANALYSIS 305
12.7.3. PRODUCT PORTFOLIO 306
12.7.4. RECENT DEVELOPMENTS 307
12.8. AIRWAY MANAGEMENT INC. 308
12.8.1. COMPANY OVERVIEW 308
12.8.2. COMPANY SNAPSHOT 308
12.8.3. PRODUCT PORTFOLIO 308
12.8.4. RECENT DEVELOPMENTS 308
12.9. THERAVENT, INC. 309
12.9.1. COMPANY OVERVIEW 309
12.9.2. COMPANY SNAPSHOT 309
12.9.3. PRODUCT PORTFOLIO 309
12.9.4. RECENT DEVELOPMENTS 309
12.10. TOMED GMBH 310
12.10.1. COMPANY OVERVIEW 310
12.10.2. REVENUE ANALYSIS 310
12.10.3. PRODUCT PORTFOLIO 310
12.10.4. RECENT DEVELOPMENTS 310
12.12. GLAXOSMITHKLINE PLC. 312
12.12.1. COMPANY OVERVIEW 312
12.12.2. REVENUE ANALYSIS 312
12.12.3. PRODUCT PORTFOLIO 312
12.12.4. RECENT DEVELOPMENTS 312
12.12. GE HEALTHCARE 313
12.12.1. COMPANY OVERVIEW 313
12.12.2. REVENUE ANALYSIS 313
12.12.3. PRODUCT PORTFOLIO 314
12.12.4. RECENT DEVELOPMENTS 314
12.13. MEDITAS 315
12.13.1. COMPANY OVERVIEW 315
12.13.2. COMPANY SNAPSHOT 315
12.13.3. PRODUCT PORTFOLIO 315
12.13.4. RECENT DEVELOPMENTS 315
12.14. MEDTRONIC 317
12.14.1. COMPANY OVERVIEW 317
12.14.2. REVENUE ANALYSIS 317
12.14.3. PRODUCT PORTFOLIO 318
12.14.4. RECENT DEVELOPMENTS 318
12.15. ACCUMED CORP. 319
12.15.1. COMPANY OVERVIEW 319
12.15.2. COMPANY SNAPSHOT 319
12.15.3. PRODUCT PORTFOLIO 319
12.15.4. RECENT DEVELOPMENTS 319
12.16. IMTHERA MEDICAL 320
12.16.1. COMPANY OVERVIEW 320
12.16.2. COMPANY SNAPSHOT 320
12.16.3. PRODUCT PORTFOLIO 320
12.16.4. RECENT DEVELOPMENTS 320
13. RELATED REPORTS 248